MentionFoxAltay Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-02.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Altay Therapeutics, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Altay Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Altay Therapeutics, Inc. →Get the full cited report on Altay Therapeutics, Inc.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Altay Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Altay Therapeutics, Inc. See pricing
Trailing twelve months. 763 filings in Biotechnology, totalled by week. The dot is this raise, $15.74M, on the same scale — one filing against the whole group's total, so it sits low by construction.
James Breitmeyer is named as Executive Officer and Director on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
Ali Ozes is named as Executive Officer on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
Eric Bjerkholt is named as Director on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
Mike Grey is named as Director on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
Ester Sklarsky is named as Director on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
Aidan King is named as Director on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
Chelsea Johnson is named as Director on the Form D that Altay Therapeutics, Inc. filed with the SEC on 2 October 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-10-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Altay Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Altay Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Altay Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Altay Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Altay Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/altay-therapeutics-inc-form-d-000001